Efficacy of Roxadustat on anemia and residual renal function in patients new to peritoneal dialysis

BACKGROUND: Both early correction of anemia and preserving residual renal function (RRF) are reported to improve patient survival. The aim of this study was to explore the efficacy and safety of Roxadustat for treatment of renal anemia in patients new to peritoneal dialysis (PD) and to assess its im...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tong, Qi, Yuanyuan, Ma, Shuang, Zhang, Lijie, Pu, Xinyu, Chen, Kui, Zhao, Ying, Sang, Shenghua, Xiao, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956311/
https://www.ncbi.nlm.nih.gov/pubmed/35318873
http://dx.doi.org/10.1080/0886022X.2022.2050754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956311/
https://www.ncbi.nlm.nih.gov/pubmed/35318873
http://dx.doi.org/10.1080/0886022X.2022.2050754

Ejemplares similares